Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor

specific

The reemergence of borderline ovarian epithelial tumor after a period of remission.

Centers

Active Trials

—

Cancer Funding

Top Centers for Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	53.3
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	53.3
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	53.3
4	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	53.3
5	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	53.3
6	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	53.3
7	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	53.3
8	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	53.3
9	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	53.3
10	Cleveland Clinic Cancer CenterCleveland, OH	—	—	53.3
11	University of Illinois Cancer CenterChicago, IL	—	—	53.3
12	Boston University Cancer CenterBoston, MA	—	—	53.3
13	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	53.3
14	Cancer Center at IllinoisUrbana, IL	—	—	53.3
15	Princess Margaret Cancer CentreToronto, ON	—	—	53.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →